These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022. Fleming-Dutra KE; Wallace M; Moulia DL; Twentyman E; Roper LE; Hall E; Link-Gelles R; Godfrey M; Woodworth KR; Anderson TC; Rubis AB; Shanley E; Jones JM; Morgan RL; Brooks O; Talbot HK; Lee GM; Bell BP; Daley M; Meyer S; Oliver SE MMWR Morb Mortal Wkly Rep; 2022 Jul; 71(26):859-868. PubMed ID: 35771731 [TBL] [Abstract][Full Text] [Related]
5. Bullous pemphigoid after second dose of mRNA- (Pfizer-BioNTech) Covid-19 vaccine: A case report. Alshammari F; Abuzied Y; Korairi A; Alajlan M; Alzomia M; AlSheef M Ann Med Surg (Lond); 2022 Mar; 75():103420. PubMed ID: 35251600 [TBL] [Abstract][Full Text] [Related]
6. Finally, an FDA Approval for an Immunization Against COVID-19: Hope on the Horizon. Powell J; Piszczatoski CR Ann Pharmacother; 2022 Sep; 56(9):1058-1064. PubMed ID: 35012364 [TBL] [Abstract][Full Text] [Related]
7. Lymphatic osteopathic manipulative treatment and soreness after receiving the COVID-19 vaccine. Sookaromdee P; Wiwanitkit V J Osteopath Med; 2022 Mar; 122(8):441. PubMed ID: 35334186 [No Abstract] [Full Text] [Related]
8. Response to "Lymphatic osteopathic manipulative treatment and soreness after receiving the COVID-19 vaccine". Marshall S J Osteopath Med; 2022 May; 122(8):443-444. PubMed ID: 35512108 [No Abstract] [Full Text] [Related]
9. Evaluation of hematological parameters and thrombocytopenia following Pfizer-BioNTech (BNT162b2) SARS-CoV-2 vaccination. Algaissi A; Alamer E; Jeraiby M; Alomaish A; Elrhima O; Qumayi S; Qasir NA; Areeshi H; Masmali A; Alhazmi A Saudi Med J; 2022 Jun; 43(6):567-571. PubMed ID: 35675927 [TBL] [Abstract][Full Text] [Related]
10. Vulvar Aphthous Ulcer Following Pfizer-BioNTech COVID-19 Vaccine - A Case Report. Drucker A; Corrao K; Gandy M J Pediatr Adolesc Gynecol; 2022 Apr; 35(2):165-166. PubMed ID: 34718079 [TBL] [Abstract][Full Text] [Related]
11. Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5-11 Years - United States, May 17-July 31, 2022. Hause AM; Baggs J; Marquez P; Myers TR; Su JR; Hugueley B; Thompson D; Gee J; Shimabukuro TT; Shay DK MMWR Morb Mortal Wkly Rep; 2022 Aug; 71(33):1047-1051. PubMed ID: 35980875 [TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study. Monin L; Laing AG; Muñoz-Ruiz M; McKenzie DR; Del Molino Del Barrio I; Alaguthurai T; Domingo-Vila C; Hayday TS; Graham C; Seow J; Abdul-Jawad S; Kamdar S; Harvey-Jones E; Graham R; Cooper J; Khan M; Vidler J; Kakkassery H; Sinha S; Davis R; Dupont L; Francos Quijorna I; O'Brien-Gore C; Lee PL; Eum J; Conde Poole M; Joseph M; Davies D; Wu Y; Swampillai A; North BV; Montes A; Harries M; Rigg A; Spicer J; Malim MH; Fields P; Patten P; Di Rosa F; Papa S; Tree T; Doores KJ; Hayday AC; Irshad S Lancet Oncol; 2021 Jun; 22(6):765-778. PubMed ID: 33930323 [TBL] [Abstract][Full Text] [Related]
14. [Humoral immunity against SARS-CoV-2 in workers of social health care centers of Castilla y León after vaccination with the BNT162b2 mRNA vaccine from Pfizer/Biontech.]. Casas Fischer R Rev Esp Salud Publica; 2021 Oct; 95():. PubMed ID: 34690347 [TBL] [Abstract][Full Text] [Related]
16. Extensive Cerebral Venous Sinus Thrombosis (CVST) After the First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine without Thrombotic Thrombocytopenia Syndrome (TTS) in a Healthy Woman. Alhashim A; Hadhiah K; Al Khalifah Z; Alhaddad FM; Al ARhain SA; Bin Saif FH; Abid A; Al Gamdi O; Alsulaiman F; AlQarni M Am J Case Rep; 2022 Feb; 23():e934744. PubMed ID: 35136010 [TBL] [Abstract][Full Text] [Related]
17. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia. Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883 [TBL] [Abstract][Full Text] [Related]
18. Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients. Rabinowich L; Grupper A; Baruch R; Ben-Yehoyada M; Halperin T; Turner D; Katchman E; Levi S; Houri I; Lubezky N; Shibolet O; Katchman H J Hepatol; 2021 Aug; 75(2):435-438. PubMed ID: 33892006 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis. Yau K; Abe KT; Naimark D; Oliver MJ; Perl J; Leis JA; Bolotin S; Tran V; Mullin SI; Shadowitz E; Gonzalez A; Sukovic T; Garnham-Takaoka J; de Launay KQ; Takaoka A; Straus SE; McGeer AJ; Chan CT; Colwill K; Gingras AC; Hladunewich MA JAMA Netw Open; 2021 Sep; 4(9):e2123622. PubMed ID: 34473256 [TBL] [Abstract][Full Text] [Related]
20. Frequency and Characteristics of Nodal and Deltoid FDG and Schroeder DG; Jang S; Johnson DR; Takahashi H; Navin PJ; Broski SM; Thorpe MP; Johnson GB; Young JR AJR Am J Roentgenol; 2021 Nov; 217(5):1206-1216. PubMed ID: 34009000 [No Abstract] [Full Text] [Related] [Next] [New Search]